Nesher Technologies, Inc.
Nanobiotech for smarter diagnostics and cutting-edge biomedical research

Products : Overview

NTI intends to commercialize the ALEX technology for basic research, drug discovery/lead optimization, biomarker validation, and medical diagnostic applications, involving analyzer and reagent products as well as ancillary services. While versions of the ALEX analyzer (2- and 3-colors) will be offered to academic labs and pharmaceutical/biotech companies for particular applications involving custom designed reagents and services, NTI’s long-term goal is to commercialize the ALEX analyzer as an IVD device along with corresponding reagent kits. The technology permits detection and quantification of biomolecules in complex matrices (e.g. serum, plasma, urine, saliva, cerebrospinal fluid, synovial fluid), and is thus particularly useful for IVD applications.